Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Johnson & Johnson Innovation – Jjdc
AddedFeb 13, 2024
UpdatedJul 16, 2026
Johnson & Johnson Innovation – Jjdc

Johnson & Johnson Innovation – Jjdc

Operating

Johnson & Johnson Innovation, based in Cambridge, MA, accelerates early-stage innovation across healthcare sectors.

Location
Cambridge, MA, US
Founded
1973
Firm
Compare
Portfolio
Employees

Johnson & Johnson Innovation accelerates early-stage innovation through strategic collaboration.

It connects potential collaborators to resources with the goal of assisting them in advancing transformation science and technology across the pharmaceutical, medical device, and consumer healthcare spectrums.

Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments48
Current Portfolio Count34
Total Portfolio Exits1

Top Investment Stages

Series B15 (34.9%)
Series A13 (30.2%)
Series C7 (16.3%)
Series Unknown5 (11.6%)
Series D3 (7.0%)

Stage Mix

Series B 35%Series A 30%Series C 16%Series Unknown 12%Series D 7%

Concentration shown as share of disclosed investments by stage.

Recent Investments

SonoThera logo

SonoThera

Accent Therapeutics logo

Accent Therapeutics

Aro Biotherapeutics logo

Aro Biotherapeutics

On Target Laboratories logo

On Target Laboratories

RefleXion Medical logo

RefleXion Medical

Jurata Thin Film logo

Jurata Thin Film

Arialys Therapeutics logo

Arialys Therapeutics

Rome Therapeutics logo

Rome Therapeutics

Rapport Therapeutics logo

Rapport Therapeutics

Solenic Medical logo

Solenic Medical

Perceive Biotherapeutics logo

Perceive Biotherapeutics

HistoSonics logo

HistoSonics

DocSpera logo

DocSpera

TRex Bio logo

TRex Bio

Rondo Therapeutics logo

Rondo Therapeutics

Iterative Scopes logo

Iterative Scopes

Verana Health logo

Verana Health

FlexDex logo

FlexDex

Visus Therapeutics logo

Visus Therapeutics

Ribon Therapeutics logo

Ribon Therapeutics

Thirty Madison logo

Thirty Madison

Sunday2Sunday logo

Sunday2Sunday

ONL Therapeutics logo

ONL Therapeutics

Datavant logo

Datavant

Escape Bio logo

Escape Bio

Similar Investment Firms

Partners HealthCare Innovation logo

Partners HealthCare Innovation

Sixers Innovation Lab logo

Sixers Innovation Lab

Jennus Innovation logo

Jennus Innovation

Acme Innovation logo

Acme Innovation

BioInnovation logo

BioInnovation

Center for Innovation logo

Center for Innovation

Innovation Factory logo

Innovation Factory

FedEx Innovation Lab logo

FedEx Innovation Lab

FastForward U logo

FastForward U

pavacenter.jhu.edu

Emerald Bioventures logo

Emerald Bioventures

Mass General Brigham Ventures logo

Mass General Brigham Ventures

University City Science Center logo

University City Science Center

sciencecenter.org

Innovation Global Capital logo

Innovation Global Capital

Solarpunk Ventures logo

Solarpunk Ventures

Technology Ideation logo

Technology Ideation

Johnson & Johnson Innovation – Jjdc - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 2 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services